INSTIs in women and pregnancy | Sharon Walmsley, FRCPC, MD, MSC

Rio de Janeiro HIV Clinical Forum 2018

DDIs, INSTIs, TB and hepatitis | David Back, PhD

Rio de Janeiro HIV Clinical Forum 2018

Transmitted resistance to ARVs and its impact on initial therapy | Ricardo Diaz, MD

Rio de Janeiro HIV Clinical Forum 2018

Resistance to Integrase Inhibitors | Charles Boucher, MD, PhD

Rio de Janeiro HIV Clinical Forum 2018

Integrase Inhibitors in Women and Pediatrics | Alberto Chaparro-Sánchez, MD

Mexican HIV Clinical Forum 2018

Optimal use of Integrase Inhibitors in Routine Patient Care in Mexico | Luis Soto-Ramirez, MD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Santiago Pérez Patrigeon, PhD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Samuel Navarro, MD

Mexican HIV Clinical Forum 2018

Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | Courtney Fletcher, PharmD

Mexican HIV Clinical Forum 2018

Clinical Update on Integrase Inhibitors: Recent Data | Pablo Tebas, MD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Aurelio Orta. MD

Mexican HIV Clinical Forum 2018

HIV integrase Inhibitors: A novel mechanisms of action | Francisco Flores Murrieta, PhD

Mexican HIV Clinical Forum 2018

Pharmacology and new modes of delivery | David Back, PhD

Argentina HIV Clinical Forum 2018

Clinical use of Integrase Inhibitors | Eugenia Negredo, PhD

Argentina HIV Clinical Forum 2018

Clinical case presentation | Eugenia Negredo, PhD

Argentina HIV Clinical Forum 2018

Use of Integrase Inhibitors in Latin America | Mônica Jacques de Moraes, MD, PhD

Argentina HIV Clinical Forum 2018

Use of Integrase Inhibitors in special populations | Omar Sued, MSc, MD, PhD

Argentina HIV Clinical Forum 2018

HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhD

Argentina HIV Clinical Forum 2018

Designing e-health interventions for HIV care | Joop Arends, MD

European Workshop on Healthy Living with HIV 2018

Optimizing care for women living with HIV | Laura Waters, MD, FRCP

European Workshop on Healthy Living with HIV 2018

Integrating future therapies into routine care | Anton Pozniak, MD, FRCP

European Workshop on Healthy Living with HIV 2018

Does choice of antiretroviral drugs matter for inflammation? | Cristina Mussini, MD

European Workshop on Healthy Living with HIV 2018

Oncology - Treating cancer in HIV infected patients | Mark Bower, PhD, FRCP, FRCPath

European Workshop on Healthy Living with HIV 2018

Renal health in people living with HIV | Bruce Hendry, BM, BCh, MD, PhD

European Workshop on Healthy Living with HIV 2018